Sugi Predict

Sugi Predict / Compounds / SCHEMBL160594

SCHEMBL160594

SCHEMBL160594

c1ccc2c(-c3c(P(C4CCCCC4)C4CCCCC4)ccc4ccccc34)c(P(C3CCCCC3)C3CCCCC3)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ MPI P34949 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ DNMT1 P26358 1/20 0.36
▸ CYP1B1 Q16678 2/20 0.35
▸ HPRT1 P00492 1/20 0.34
▸ EPHX1 P07099 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30391805 1.00 ALDH1A1 (0.37) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL31566355 0.98 ALDH1A1 (0.38) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL164194 0.98 ALDH1A1 (0.38) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL16811762 0.91 CYP1A2 (0.39) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL7544297 0.90 ALDH1A1 (0.35) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL5608737 0.89 DNMT1 (0.38) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL4552955 0.87 ALDH1A1 (0.33) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL1365289 0.87 MAPT (0.58) ALDH1A1MAPTKDM4EMEN1RAB9A
SCHEMBL17758852 0.87 ALDH1A1 (0.33) ALDH1A1HSD17B10MAPTHIF1AMPI
SCHEMBL9350829 0.87 DNMT1 (0.39) ALDH1A1HSD17B10MAPTMPICYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096445-A1 SYNTHESIS OF INTERMEDIATES FOR THE PREPARATION OF MACROCYCLIC COMPOUNDS ALKERMES, INC. (US) 2025-05-08 — — WO claimed
EP-2981560-B1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD LLC 2 (US) 2021-10-13 — — EP claimed
EP-2981560-A1 CURING OF LIQUID THERMOSETTING RESINS Reichhold, Inc. (US) 2016-02-10 — — EP claimed
US-9068045-B2 Curing of liquid thermosetting resins REICHHOLD, INC. (US) 2015-06-30 — — US claimed
US-20140303315-A1 CURING OF LIQUID THERMOSETTING RESINS Polynt Composites USA Inc. 2014-10-09 — — US claimed
WO-2014165425-A1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD, INC. (US) 2014-10-09 — — WO claimed
EP-1650207-B1 Process for producing optically active 3-quinuclidinols TAKASAGO PERFUMERY CO LTD (JP) 2007-06-27 — — EP claimed
EP-1598053-B1 Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres OREAL (FR) 2006-12-20 — — EP claimed
US-20050251928-A1 Method for stripping artificial color from keratin fibers L'OREAL (FR) 2005-11-17 — — US claimed
US-12071498-B2 Radically polymerizable compositions Polynt Composites USA, Inc. (US) 2024-08-27 — — US disclosed
US-20230257500-A1 RADICALLY POLYMERIZABLE COMPOSITIONS BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) 2023-08-17 — — US disclosed
US-20230165771-A1 PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION L'OREAL (FR) 2023-06-01 — — US disclosed
EP-4171490-A1 PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION L'OREAL (FR) 2023-05-03 — — EP disclosed
US-11518834-B2 Radically polymerizable compositions Polynt Composites USA, Inc. (US) 2022-12-06 — — US disclosed
EP-0580336-A1 Process for preparing optically active 4-methyl-2-oxetanone TAKASAGO INTERNATIONAL CORPORATION (JP) 1994-01-26 — — EP disclosed
US-5274146-A Water-soluble alkali metal sulfonate-substituted binaphthylphosphine transition metal complex and enantioselective hydrogenation method using it TAKASAGO INTERNATIONAL CORPORATION (JP) 1993-12-28 — — US disclosed
EP-0544455-A1 Water-soluble alkali metal sulfonate-substituted binaphthylphosphine transition metal complex and enantioselective hydrogenation method using it TAKASAGO INTERNATIONAL CORPORATION (JP) 1993-06-02 — — EP disclosed
US-5206399-A 2,2'-BIS(DIPHENYLPHOSPHINO)-5,5',6,6',7,7',8,8'-OCTAHYDRO-1,1'-BINAPHTHYL AND TRANSITION METAL COMPLEX CONTAINING THE SAME AS LIGAND TAKASAGO INTERNATIONAL CORPORATION (JP) 1993-04-27 — — US disclosed
EP-0479542-A1 A phosphino binaphthyl compound and transition metal complexes thereof Takasago International Corporation (JP) 1992-04-08 — — EP disclosed
EP-0466405-A1 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof Takasago International Corporation (JP) 1992-01-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165771-A1 PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION KRT18, CKAP4, VIM ALDH1A1 4235/4885HSD17B10 4142/4885MAPT 334/4885
US-20050251928-A1 Method for stripping artificial color from keratin fibers KRT18, DSG1, JUP ALDH1A1 4512/4885HSD17B10 3083/4885MAPT 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.